Moss KJ - Search Results

1

Fallopian Tube-Derived Tumor Cells Induce Testosterone Secretion from the Ovary, Increasing Epithelial Proliferation and Invasion.

Colina JA, Zink KE, Eliadis K, Salehi R, Gargus ES, Wagner SR, Moss KJ, Baligod S, Li K, Kirkpatrick BJ, Woodruff TK, Tsang BK, Sanchez LM, Burdette JE. Colina JA, et al. Among authors: moss kj. Cancers (Basel). 2021 Apr 16;13(8):1925. doi: 10.3390/cancers13081925. Cancers (Basel). 2021. PMID: 33923536 Free PMC article.

2

An Ovarian Steroid Metabolomic Pathway Analysis in Basal and Polycystic Ovary Syndrome (PCOS)-like Gonadotropin Conditions Reveals a Hyperandrogenic Phenotype Measured by Mass Spectrometry.

Gargus ES, Bae Y, Chen J, Moss KJ, Ingram AN, Zhang J, Montgomery NT, Boots CE, Funk WE, Woodruff TK. Gargus ES, et al. Among authors: moss kj. Biomedicines. 2022 Jul 8;10(7):1646. doi: 10.3390/biomedicines10071646. Biomedicines. 2022. PMID: 35884951 Free PMC article.

3

Advancing Health Equity Through Issue Spotting in Primary Care: A Case for Medical-legal Partnerships.

Moss KJ, Bondurant J, Gievers L, Mutrie L. Moss KJ, et al. J Pediatr Health Care. 2024 Mar-Apr;38(2):279-284. doi: 10.1016/j.pedhc.2023.11.002. J Pediatr Health Care. 2024. PMID: 38429042

4

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection.

Acosta CJ, Diaz C, Nordio F, Han HH, Moss KJ, Bohning K, Kumar P, Liu M, Patel H, Pacciarini F, Mwangi V, Walter E, Powell TD, El Sahly HM, Baldwin WR, Santangelo J, Anderson EJ, Dubin G. Acosta CJ, et al. Among authors: moss kj. J Infect Dis. 2023 May 29;227(11):1303-1312. doi: 10.1093/infdis/jiac482. J Infect Dis. 2023. PMID: 36484441 Free PMC article. Clinical Trial.

5

A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate.

Jackson LA, Rupp R, Papadimitriou A, Wallace D, Raanan M, Moss KJ. Jackson LA, et al. Among authors: moss kj. Vaccine. 2018 Jun 22;36(27):3976-3983. doi: 10.1016/j.vaccine.2018.05.028. Epub 2018 May 19. Vaccine. 2018. PMID: 29789238 Free article. Clinical Trial.

6

Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.

Butrapet S, Childers T, Moss KJ, Erb SM, Luy BE, Calvert AE, Blair CD, Roehrig JT, Huang CY. Butrapet S, et al. Among authors: moss kj. Virology. 2011 Apr 25;413(1):118-27. doi: 10.1016/j.virol.2011.01.030. Epub 2011 Feb 24. Virology. 2011. PMID: 21353281 Free article.

7

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.

Erb SM, Butrapet S, Moss KJ, Luy BE, Childers T, Calvert AE, Silengo SJ, Roehrig JT, Huang CY, Blair CD. Erb SM, et al. Among authors: moss kj. Virology. 2010 Oct 25;406(2):328-35. doi: 10.1016/j.virol.2010.07.024. Epub 2010 Aug 13. Virology. 2010. PMID: 20708768 Free article.

8

The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion.

Huang CY, Butrapet S, Moss KJ, Childers T, Erb SM, Calvert AE, Silengo SJ, Kinney RM, Blair CD, Roehrig JT. Huang CY, et al. Among authors: moss kj. Virology. 2010 Jan 20;396(2):305-15. doi: 10.1016/j.virol.2009.10.027. Epub 2009 Nov 12. Virology. 2010. PMID: 19913272 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page